DAXOR CORP. news, videos and press releases
For more news please use our advanced search feature.
DAXOR CORP. - More news...
DAXOR CORP. - More news...
- Daxor Corporation Announces New Data on Blood Volume Analysis from Duke and Yale Universities Presented at THT 2025
- Daxor to Exhibit at World's Largest Critical Care Conference
- Daxor's Blood Volume Analysis Uncovers Hidden Heart Failure Subtype in Nearly 1 in 5 Patients, Enabling Targeted Treatment
- New Multicenter Study Highlights Utility of Daxor’s Blood Volume Analysis in Heart Failure Care
- Daxor Expands Its BVA-100™ Blood Volume Diagnostic to Two New Hospital Systems Adding to Sales Momentum
- DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24
- Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
- Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device
- Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024
- Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management
- Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee
- Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care
- Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter
- Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network
- Daxor Corporation Awarded $1.9M Contract by The U.S. Air Force for Development of its Next Generation Tracer System in its Point-of-Care Blood Volume Analyzer
- Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide
- Daxor Corporation Awarded New U.S. Defense Health Agency Contract for Added Capabilities to Its Point-of-Care Blood Volume Analyzer
- Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide
- Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting
- Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer
- New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion
- DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™)
- Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital
- Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24
- Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics
- Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024
- Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023
- Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
- Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base
